GA NCORP

TRIALS & PROVIDERS

Menu

NCORP Trials

Cancer Type = Melanoma

1.
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients with Advanced Melanoma
Cancer Type
Melanoma, Unknown Primary
NCI ID
NCT02339571
Protocol IDs
EA6141 (primary)
NCI-2014-02674
Treatment Sites (5)
Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
Savannah
Alaina Underberg
912-819-5778
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org
2.
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients with Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
Cancer Type
Melanoma
NCI ID
NCT04462406
Protocol IDs
EA6192 (primary)
EA6192
NCI-2020-04463
Treatment Sites (1)
Summit Cancer Care at the Nancy N. Lewis and J.C. Lewis Cancer & Research Pavilion
Savannah
For a complete listing of all trials matching your criteria in Georgia, please visit GeorgiaCancerInfo.org
1-2 of 2 Trials
CALL EMAIL

Copyright © 2015, Georgia NCI Community Oncology Research Program. All Rights Reserved.
Powered by GeorgiaCancerInfo.org
Website Design & Development by Peachtree Solutions.